Next-generation immunotherapy offers new hope for beating brain cancer
High-grade glioma is the most aggressive form of brain cancer. Despite improvements in surgical procedures, chemotherapy, and radiotherapy, this type of brain tumour is still notoriously hard to treat: less than 10% of patients survive beyond five years. Researchers from KU Leuven have now shown that next-generation cell-based immunotherapy may offer new hope in the […]
